FWA
ANIX icon

Freedom Wealth Alliance’s Anixa Biosciences ANIX Stock Holding History

Freedom Wealth Alliance’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,453
Closed -$23.2K – 87
2022
Q4 		$23.2K Buy
+5,453
New +$26.2K 0.03% 182

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Freedom Wealth Alliance's ANIX Position: Q1 2023 in Review

Freedom Wealth Alliance sold out of Anixa Biosciences (ANIX) in Q1 2023, closing a stake of 5,453 shares — an estimated $23.2K sold.

Freedom Wealth Alliance first reported a position in ANIX in Q4 2022 and held it in 1 quarter. The position peaked at $23.2K in Q4 2022. 44 funds tracked by Wall St. Rank hold ANIX as of Q1 2023.

  • Freedom Wealth Alliance reported no remaining Anixa Biosciences position as of Q1 2023 after selling out during the quarter.
  • Freedom Wealth Alliance sold 5,453 Anixa Biosciences shares in Q1 2023, an estimated $23.2K.
  • Freedom Wealth Alliance first reported a position in Anixa Biosciences in Q4 2022 and held it in 1 quarter.
  • Freedom Wealth Alliance's Anixa Biosciences position peaked at $23.2K in Q4 2022.
  • 44 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2023.

Based on Freedom Wealth Alliance's 13F filing for Q1 2023, filed 25 Apr 2023.